Genfit SA (GNFT)
4.21
-0.03
(-0.71%)
USD |
NASDAQ |
Nov 22, 12:38
Genfit Enterprise Value: 212.18M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 212.18M |
| November 20, 2024 | 215.67M |
| November 19, 2024 | 213.32M |
| November 18, 2024 | 218.67M |
| November 15, 2024 | 225.15M |
| November 14, 2024 | 226.90M |
| November 13, 2024 | 260.59M |
| November 12, 2024 | 260.67M |
| November 11, 2024 | 261.59M |
| November 08, 2024 | 261.59M |
| November 07, 2024 | 285.54M |
| November 06, 2024 | 279.87M |
| November 05, 2024 | 289.53M |
| November 04, 2024 | 288.04M |
| November 01, 2024 | 294.02M |
| October 31, 2024 | 292.53M |
| October 30, 2024 | 292.53M |
| October 29, 2024 | 275.56M |
| October 28, 2024 | 275.56M |
| October 25, 2024 | 275.06M |
| October 24, 2024 | 279.55M |
| October 23, 2024 | 285.04M |
| October 22, 2024 | 299.76M |
| October 21, 2024 | 297.27M |
| October 18, 2024 | 297.02M |
| Date | Value |
|---|---|
| October 17, 2024 | 316.48M |
| October 16, 2024 | 313.99M |
| October 15, 2024 | 295.52M |
| October 14, 2024 | 305.50M |
| October 11, 2024 | 303.01M |
| October 10, 2024 | 277.11M |
| October 09, 2024 | 277.56M |
| October 08, 2024 | 279.30M |
| October 07, 2024 | 273.06M |
| October 04, 2024 | 269.38M |
| October 03, 2024 | 265.08M |
| October 02, 2024 | 257.38M |
| October 01, 2024 | 253.26M |
| September 30, 2024 | 298.52M |
| September 27, 2024 | 285.04M |
| September 26, 2024 | 280.55M |
| September 25, 2024 | 269.07M |
| September 24, 2024 | 264.08M |
| September 23, 2024 | 249.61M |
| September 20, 2024 | 242.12M |
| September 19, 2024 | 209.68M |
| September 18, 2024 | 217.17M |
| September 17, 2024 | 211.68M |
| September 16, 2024 | 206.94M |
| September 13, 2024 | 205.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.99M
Minimum
Jun 13 2022
736.39M
Maximum
May 11 2020
167.39M
Average
137.01M
Median
May 26 2023
Enterprise Value Benchmarks
| Edap TMS SA | 68.17M |
| DBV Technologies SA | 1.221M |
| Cellectis SA | -28.39M |
| Adaptimmune Therapeutics PLC | 26.67M |
| Akari Therapeutics PLC | 24.35M |
Enterprise Value Related Metrics
| Revenue (Quarterly) | 15.36M |
| Earnings Yield | 2.68% |
| Operating Earnings Yield | 5.09% |
| Normalized Earnings Yield | 2.500 |